J&J explores $20 billion sale of orthopedics unit, source says

J&J last ​year said it had planned to separate its orthopedics unit, known ​as DePuy Synthes, into a standalone company within the next 18 to 24 months, marking its second major spinoff ​in two years as it sharpens ⁠focus on ‌higher-growth healthcare segments.